Atlas Trials

Use of Flaxseed(Alpha Linolenic Acid) Powder in Morbidly Obese Patients With Systemic Inflammation

Clinical trial NCT00502021 · UNKNOWN

Trial details

NCT number
NCT00502021
Sponsor
University of Sao Paulo
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Morbid ObesityAtherosclerosisSystemic Inflammation
Start date
2007-08-01
Primary completion
2013-08-01
Enrollment
90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.